Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.Br J Dermatol. 1997 Nov; 137(5):808-11.BJ
Abstract
We report three cases of acute generalized exanthematous pustulosis (AGEP) following oral administration of nystatin. All cases showed similar clinical features and histopathological findings, and a delayed-type hypersensitivity to nystatin could be demonstrated in patch and prick testing. Drug eruptions to nystatin are extremely rare, and, to our knowledge. AGEP has not been reported previously.
Links
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
9415247
Citation
Küchler, A, et al. "Acute Generalized Exanthematous Pustulosis Following Oral Nystatin Therapy: a Report of Three Cases." The British Journal of Dermatology, vol. 137, no. 5, 1997, pp. 808-11.
Küchler A, Hamm H, Weidenthaler-Barth B, et al. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. Br J Dermatol. 1997;137(5):808-11.
Küchler, A., Hamm, H., Weidenthaler-Barth, B., Kämpgen, E., & Bröcker, E. B. (1997). Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. The British Journal of Dermatology, 137(5), 808-11.
Küchler A, et al. Acute Generalized Exanthematous Pustulosis Following Oral Nystatin Therapy: a Report of Three Cases. Br J Dermatol. 1997;137(5):808-11. PubMed PMID: 9415247.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
AU - Küchler,A,
AU - Hamm,H,
AU - Weidenthaler-Barth,B,
AU - Kämpgen,E,
AU - Bröcker,E B,
PY - 1998/2/12/pubmed
PY - 1998/2/12/medline
PY - 1998/2/12/entrez
SP - 808
EP - 11
JF - The British journal of dermatology
JO - Br J Dermatol
VL - 137
IS - 5
N2 - We report three cases of acute generalized exanthematous pustulosis (AGEP) following oral administration of nystatin. All cases showed similar clinical features and histopathological findings, and a delayed-type hypersensitivity to nystatin could be demonstrated in patch and prick testing. Drug eruptions to nystatin are extremely rare, and, to our knowledge. AGEP has not been reported previously.
SN - 0007-0963
UR - https://www.unboundmedicine.com/medline/citation/9415247/Acute_generalized_exanthematous_pustulosis_following_oral_nystatin_therapy:_a_report_of_three_cases_
L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=1997&volume=137&issue=5&spage=808
DB - PRIME
DP - Unbound Medicine
ER -